Insider Transactions in Q1 2023 at Merrimack Pharmaceuticals Inc (MACK)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 21
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
160,590
+8.38%
|
$1,766,490
$11.52 P/Share
|
|
Jan 31
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
2,232
+0.14%
|
$24,552
$11.4 P/Share
|
|
Jan 30
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
24,708
+1.51%
|
$271,788
$11.36 P/Share
|
|
Jan 27
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
21,875
+1.36%
|
$240,625
$11.4 P/Share
|
|
Jan 12
2023
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+8.2%
|
$1,100,000
$11.9 P/Share
|
|
Jan 06
2023
|
Ana Radeljevic |
BUY
Open market or private purchase
|
Direct |
4,156
+50.0%
|
$49,872
$12.03 P/Share
|
|
Jan 03
2023
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect |
30,632
+2.16%
|
$336,952
$11.33 P/Share
|
|
Jan 03
2023
|
Noah G. Levy Director |
BUY
Open market or private purchase
|
Indirect |
5,300
+0.52%
|
$58,300
$11.24 P/Share
|